Search results for "Myocardial"

showing 10 items of 1323 documents

Apolipoprotein E Genotypic Frequencies Among Down Syndrome Patients Imply Early Unsuccessful Aging for ApoE4 Carriers

2007

Down syndrome (DS) might be considered a model for unsuccessful and early aging, possibly accelerated for those who carry the APOE4 allele associated with common age-related diseases, e.g., Alzheimer's disease and a poor prognosis after acute myocardial infarction, causing lower ApoE4 frequencies among the very old in general populations. We compared ApoE genotypic frequencies found for healthy adults (n = 211, age 90) to those found for DS patients (n = 106, mean age 9 years), all living in western Sicily. We found that the frequency of the ApoE23 genotype increased with age among the healthy adults (8.5%, 6.4%, 19.7%; p = 0.024) while ApoE34 frequency decreased (16.1%, 12.6%, 4.1%; p = 0.…

AdultMaleApolipoprotein EAgingmedicine.medical_specialtyPathologyDown syndromeAdolescentGenotypeChromosomes Human Pair 21Down syndromeApolipoprotein E4DiseaseBiologyGastroenterologySettore MED/38 - Pediatria Generale E SpecialisticaInternal medicineGenotypemedicineHumansSettore MED/05 - Patologia ClinicaMyocardial infarctionChildapolipoprotein EInfantSequence Analysis DNAPrognosismedicine.diseaseGenotype frequencyAgeingChild PreschoolFemaleGeriatrics and GerontologyChromosome 21Rejuvenation Research
researchProduct

Prevalence of Apolipoprotein E Alleles in Healthy Subjects and Survivors of Ischemic Stroke

1998

Background and Purpose —The ε4 allele of the apolipoprotein E (apoE) has been related to the occurrence of myocardial infarction, but its association with ischemic stroke is controversial. We have evaluated the relation between apoE alleles and the occurrence of cerebrovascular ischemia. Methods —The apoE ε genotypes of 100 patients with a documented history of ischemic stroke without clinically apparent dementia (stroke+) and 108 subjects without such history (stroke−) were determined. The relative frequency of the apoE alleles and genotypes was estimated in 398 healthy subjects aged <40 years from the same ethnic background. Results —The frequency of the apoE ε4 allele in stroke+ (0.1…

AdultMaleApolipoprotein Emedicine.medical_specialtyGastroenterologyBrain IschemiaCentral nervous system diseaseApolipoproteins EReference ValuesRisk FactorsInternal medicineOdds RatiomedicineHumansSurvivorsMyocardial infarctionRisk factorAlleleStrokeAllelesAgedAged 80 and overAdvanced and Specialized Nursingbusiness.industryDementia VascularHomozygoteCase-control studyMiddle Agedmedicine.diseaseThrombosisSurgeryItalyCase-Control StudiesFemaleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke
researchProduct

Learning by heart : cardiac cycle reveals an effective time window for learning

2018

Cardiac cycle phase is known to modulate processing of simple sensory information. This effect of the heartbeat on brain function is likely exerted via baroreceptors, the neurons sensitive for changes in blood pressure. From baroreceptors, the signal is conveyed all the way to the forebrain and the medial prefrontal cortex. In the two experiments reported, we examined whether learning, as a more complex form of cognition, can be modulated by the cardiac cycle phase. Human participants ( experiment 1) and rabbits ( experiment 2) were trained in trace eyeblink conditioning while neural activity was recorded. The conditioned stimulus was presented contingently with either the systolic or dias…

AdultMaleBaroreceptorAdolescentPhysiologyComputer sciencehippocampusclassical conditioningtheta oscillationEffective timeStimulus (physiology)verenkiertota3112050105 experimental psychology03 medical and health sciencesYoung Adult0302 clinical medicineHeart RateAnimalsHumans0501 psychology and cognitive scienceshippokampusCA1 Region Hippocampalta515Cardiac cycleGeneral Neuroscience05 social sciencesClassical conditioningAssociation LearningBrainElectroencephalographybaroreceptorMyocardial ContractionConditioning EyelidehdollistuminenAcoustic StimulationNeural processingEvoked Potentials AuditoryFemaleRabbitsNeuroscience030217 neurology & neurosurgeryJournal of Neurophysiology
researchProduct

Association between platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31) polymorphisms and acute myocardial infarction: a study in patien…

2004

Summary Adhesion of circulating cells to the arterial surface is among the first detectable events in atherogenesis. Cellular adhesion molecules, expressed by the vascular endothelium and by circulating leucocytes, mediate cell recruitment and their transendothelial migration. Platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31), involved in this migration, has been associated with the developmental course of atherosclerosis. A few studies have investigated an association between coronary heart disease and single nucleotide polymorphisms (SNPs) located in functionally important domains of the PECAM-1/CD31 gene. In particular, Ser563Asn and Gly670Arg SNPs have been described as s…

AdultMaleCD31GenotypeCell adhesion moleculeImmunologyMyocardial InfarctionSingle-nucleotide polymorphismOdds ratioMiddle AgedBiologymedicine.diseasePlatelet Endothelial Cell Adhesion Molecule-1Gene FrequencyCase-Control StudiesImmunologyGenotypeGeneticsmedicineHumansGenetic Predisposition to DiseaseMyocardial infarctionCell adhesionSicilyAllele frequency
researchProduct

Sublingual administration of captopril in patients with acute myocardial ischemia.

1991

Summary: To investigate the anti-ischemic capability of the angiotensin-converting enzyme inhibitor captopril, 10 patients with acute myocardial ischemia (angina pectoris >1 h, ST-segment depression ±0.1 mV, no rise in creatine phosphokinase) received 25 mg captopril sublingually after being treated with an intravenous infusion of nitroglycerin (3 mg/h) and heparin (1200 IU/h) for 1 hour. A control group of 10 patients received placebo instead of captopril. Results showed a decrease of the initial ST-segment depression from 0.25±0.04 to 0.2±0.03 mV (p>0.01) with nitroglycerin for the captopril group and from 0.26±0.05 to 0.21±0.05 mV (p>0.01) for the control group. An additional decrease to…

AdultMaleCaptoprilAdministration SublingualCoronary DiseasePlaceboSublingual administrationAngina PectorisAnginaElectrocardiographyNitroglycerinHeart ratemedicineHumanscardiovascular diseasesMyocardial infarctionCreatine KinaseClinical Trials as Topicbiologybusiness.industryHemodynamicsCaptoprilGeneral MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureAnesthesiaAcute DiseaseVascular resistancebiology.proteinCreatine kinaseDrug Therapy CombinationFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugClinical cardiology
researchProduct

Decision making in a presumptive case of STEMI-like myocarditis

2015

In youngmales, differential diagnosis during chest pain is not always easy. When ECG findings suggest a cardiac origin of such symptoms, myo-pericarditis is usually themost likely hypothesis, beingmore common than Acute Coronary Syndromes (ACS) in the first decades of life [1]. In the presence of ST segment elevation, Troponin release and ventricular wall motion abnormalities, the diagnosis can be challenging, though. In the young a lowcoronary risk profile and atypical symptoms seldom support a working diagnosis of Coronary Heart Disease (CHD), and, therefore, urgent coronary angiography is not recommended routinely, although cases of early ACS are not so rare. In October 2014 a 26-year-ol…

AdultMaleChest Painmedicine.medical_specialtyMyocarditisCath labClinical Decision-MakingMyocarditiPopulationMyocardial InfarctionCoronary AngiographyChest painElectrocardiographyCoronary thrombosisInternal medicinemedicineMyocardial infarctioneducationCreatine KinaseST depressioneducation.field_of_studybusiness.industrymedicine.diseaseTroponinCardiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessTIMIHumanInternational Journal of Cardiology
researchProduct

Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database.

2013

Background— We aimed to assess in-hospital case fatality and 1-year prognosis in HIV-infected patients with acute myocardial infarction. Methods and Results— From the PMSI (Program de Medicalisation des Systèmes d’informatique) database, data from 277 303 consecutive acute myocardial infarction patients hospitalized from January 1, 2005, to December 31, 2009, were analyzed. Surviving patients were followed up for 1 year after discharge. HIV-infected patients were compared with uninfected patients. Among the cohort, HIV-infected patients (n=608) accounted for 0.22%. All-cause hospital and 1-year mortality rates were lower in the HIV-infected group than in uninfected patients (3.1% versus 8.…

AdultMaleDatabases FactualStatistics as TopicMyocardial InfarctionHIV Infectionscomputer.software_genreCohort StudiesPhysiology (medical)Case fatality ratemedicineHumansMyocardial infarctionMedical Informatics ApplicationsAgedRetrospective StudiesAged 80 and overIschemic cardiomyopathyDatabasebusiness.industryMortality rateRetrospective cohort studyMiddle Agedmedicine.diseaseHospitalizationTreatment OutcomeCohortFemaleMyocardial infarction diagnosisFranceCardiology and Cardiovascular MedicinebusinesscomputerCohort studyCirculation
researchProduct

Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes

2013

The safety of BVS implantation in patients with a high risk for early thrombotic complications has not been studied. We report on the outcomes of patients with acute coronary syndromes (ACS) treated with bioresorbable, everolimus-eluting, vascular scaffolds (BVS).150 consecutive patients with ACS (194 lesions) treated with BVS between May 2012 and July 2013 were compared with a control group composed of 103 consecutive patients (129 lesions) who underwent everolimus drug-eluting stent (DES) implantation in the same time period. The incidence of major adverse cardiac events (MACE: death, non-fatal myocardial infarction, or reintervention) before discharge, at one month and six months was eva…

AdultMaleDrugmedicine.medical_specialtyTime Factorsmedia_common.quotation_subjectmedicine.medical_treatmentmedicineHumansIn patientEverolimusMyocardial infarctionAcute Coronary SyndromeAgedmedia_commonAged 80 and overSirolimusEverolimusbusiness.industryIncidence (epidemiology)StentCardiovascular AgentsDrug-Eluting StentsMiddle Agedmedicine.diseaseThrombosisSurgeryTreatment OutcomeFemaleCardiology and Cardiovascular MedicinebusinessMacemedicine.drugEuroIntervention
researchProduct

Rosuvastatin Prevents Conduit Artery Endothelial Dysfunction Induced by Ischemia and Reperfusion by a Cyclooxygenase-2–Dependent Mechanism

2010

ObjectivesThe purpose of this study was to determine whether single-dose rosuvastatin (40 mg) protects against ischemia and reperfusion (IR)–induced endothelial dysfunction in humans and whether this effect is cyclooxygenase (COX)-2 dependent.BackgroundAnimal studies have demonstrated that rosuvastatin can limit damage and improve recovery after IR.MethodsIn a double-blind, parallel design, 20 volunteers were randomized to a single dose of oral rosuvastatin (40 mg) or placebo. Twenty-four hours later, endothelium-dependent, flow-mediated dilation (FMD) of the radial artery was measured before and after IR (15 min of upper arm ischemia followed by 15 min of reperfusion). In a separate protoc…

AdultMaleEndotheliumendotheliumAdolescentPremedicationIschemiaMyocardial Reperfusion InjuryPharmacologyPlaceboYoung AdultDouble-Blind Methodmedicineischemia reperfusionHumansRosuvastatinEndothelial dysfunctionRosuvastatin CalciumSulfonamidesCyclooxygenase 2 Inhibitorsbusiness.industryModels Cardiovascularnutritional and metabolic diseases3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitormedicine.diseaseFluorobenzenesVasodilationRosuvastatin Calciummedicine.anatomical_structurePyrimidinesCelecoxibCyclooxygenase 2AnesthesiaIschemic Preconditioning MyocardialRadial ArteryCelecoxibIschemic preconditioningPyrazolesFemaleEndothelium VascularHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessCardiology and Cardiovascular Medicinerosuvastatinmedicine.drugJournal of the American College of Cardiology
researchProduct

Timing of Triggering in Relation to the Cardiac Cycle in Nonelite Rifle Shooters

2003

This study investigated the timing of the trigger pull in relation to the cardiac cycle during air rifle shooting. Electrocardiogram) was recorded from 20 male nonelite rifle shooters in two separate testing sessions. The testing was conducted at an indoor shooting range using an optoelectronic shooting system. Each participant fired a shot in the standing position at a distance of 10 m from the target. The results showed that compared to random triggering, the shooters fired more often during the phase of 10-50% of the R wave-to-R wave (R-R) interval and less often during the phase of 50-90%. With regard to performance accuracy, the participants exhibited average or above average performan…

AdultMaleFirearmsmedicine.medical_specialtyCardiac cyclePhysical Therapy Sports Therapy and RehabilitationShooting rangeGeneral MedicineMyocardial ContractionElectrocardiographyPhysical FitnessNephrologyShot (pellet)Internal medicineHeart ratemedicineCardiologyHumansOrthopedics and Sports MedicineRifleSportsMathematicsResearch Quarterly for Exercise and Sport
researchProduct